VTP-1000 is under clinical development by Barinthus Biotherapeutics and currently in Phase I for Celiac Disease.

The stock market started off on a high note Friday, attempting to pare back some of its losses after a long five-day decline. The Dow gained 173 points, or 0.4%, while the S&P 500 and the Nasdaq ...

Yeah, a home is expensive, but these things cost way less than calling a professional to help you with those annoying home ...

The ancient manuscript rested on the shelves of the Newberry Library for more than a century. Little was known about the ...

Reddit's unique, highly engaged user base and authentic content drive growth and attract advertisers. Click here to find out ...

Cybercriminals who hacked Rhode Island’s system for health and benefits programs have released files to a site on the dark ...

The promise all good fountain pens deliver—be they expensive or affordable—is that they make your handwriting better than you ...

The City Council recently approved the city’s new “Winter Operation Plan” that covers mid-November to mid-March. It outlines ...

Listen, if we learned anything from the past few years, it's that sometimes you need to fight chaos with chaos and combat the ...

But how does one narrow it down to 50 specific watches? We queried over 50 watch-industry experts and top-tier ...

Artificial Intelligence is a very useful tool for humans, but it cannot replace critical thinking, says Peter Rose of ...

Kenosha, Wisconsin-based Snap-on Incorporated (SNA) is a designer, manufacturer, and marketer of tools and equipment for professional use in the transportation industry. With a market cap of $18 ...